- Bondy-Denomy J, Pawluk A, Maxwell KL, et al. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature. 2013;493 (7432) : 429-432. (PMID: 23242138)
- Pawluk A, Bondy-Denomy J, Cheung VH, et al. A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa. mBio. 2014;5(2):e00896. (PMID: 24736222)
- Pawluk A, Staals RH, Taylor C, et al. Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nat Microbiol. 2016;1(8):16085. (PMID: 27573108)
- Pawluk A, Amrani N, Zhang Y, et al. Naturally occurring off-switches for CRISPR-Cas9. Cell. 2016;167(7):1829-1838.e9. (PMID: 27984730)
- Rauch BJ, Silvis MR, Hultquist JF, et al. Inhibition of CRISPR-Cas9 with bacteriophage proteins. Cell. 2017;168(1-2):150-158.e10. (PMID: 28041849)
- Smargon AA, Cox DBT, Pyzocha NK, et al. Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory roteins Csx27 and Csx28. Mol Cell. 2017;65(4):618-630.e7. (PMID: 28065598)
- Hynes AP, Rousseau GM, Lemay ML, et al. An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9. Nat Microbiol. 2017;2(10):1374-1380. (PMID: 28785032)
- He F, Bhoobalan-Chitty Y, Van LB, et al. Anti-CRISPR proteins encoded by archaeal lytic viruses inhibit subtype I-D immunity. Nat Microbiol. 2018;3(4):461-469. (PMID: 29507349)
- Hynes AP, Rousseau GM, Agudelo D, et al. Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins. Nat Commun. 2018;9(1):2919. (PMID: 30046034)
- Watters KE, Fellmann C, Bai HB, et al. Systematic discovery of natural CRISPR-Cas12a inhibitors. Science. 2018;362(6411):236-239. (PMID: 30190307)
- Marino ND, Zhang JY, Borges AL, et al. Discovery of widespread type I and type V CRISPR-Cas inhibitors. Science. 2018;362(6411):240-242. (PMID: 30190308)
- Lee J, Mir A, Edraki A, et al. Potent Cas9 inhibition in bacterial and human cells by AcrIIC4 and AcrIIC5 anti-CRISPR proteins. mBio. 2018;9(6):e02321-18. (PMID: 30514786)
- Uribe RV, van der Helm E, Misiakou MA, et al. Discovery and characterization of Cas9 inhibitors disseminated across seven bacterial phyla. Cell Host Microbe. 2019;25(2):233-241.e5. (PMID: 30737174)
- Forsberg KJ, Bhatt IV, Schmidtke DT, et al. Functional metagenomics-guided discovery of potent Cas9 inhibitors in the human microbiome. Elife. 2019;8:e46540. (PMID: 31502535)
- Athukoralage JS, McMahon SA, Zhang C, et al. An anti-CRISPR viral ring nuclease subverts type III CRISPR immunity. Nature. 2020;577(7791):572-575. (PMID: 31942067)
- Watters KE, Shivram H, Fellmann C, et al. Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes. Proc Natl Acad Sci U S A. 2020;117(12):6531-6539. (PMID: 32156733)
- Mahendra C, Christie KA, Osuna BA, et al. Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer. Nat Microbiol. 2020;5(4):620-629. (PMID: 32218510)
- Eitzinger S, Asif A, Watters KE, et al. Machine learning predicts new anti-CRISPR proteins. Nucleic Acids Res. 2020;48(9):4698-4708. (PMID: 32286628)
- Osuna BA, Karambelkar S, Mahendra C, et al. Listeria phages induce Cas9 degradation to protect Lysogenic genomes. Cell Host Microbe. 2020;S1931-3128(20)30190-6. (PMID: 32325050)
- Lin P, Qin S, Pu Q, et al. CRISPR-Cas13 inhibitors block RNA editing in Bacteria and Mammalian cells. Mol Cell. 2020;78(5):850-861.e5. (PMID: 32348779)
- Peng X, Mayo-Muñoz D, Bhoobalan-Chitty Y,et al. Anti-CRISPR proteins in Archaea. Trends Microbiol. 2020;S0966-842X(20)30133-5. (PMID: 32499102)
- Gussow AB, Park AE, Borges AL, et al. Machine-learning approach expands the repertoire of anti-CRISPR protein families. Nat Commun. 2020;11(1):3784. (PMID: 32728052)
- Pinilla-Redondo R, Shehreen S, Marino N D, et al. Discovery of multiple anti-CRISPRs highlights anti-defense gene clustering in mobile genetic elements[J]. Nature communications, 2020, 11(1): 1-11. (PMID: 33159058)
- León L M, Park A E, Borges A L, et al. Mobile element warfare via crispr and anti-crispr in pseudomonas aeruginosa[J]. Nucleic acids research, 2021, 49(4): 2114-2125. (PMID: 33544853)
- Kevin J. Forsberg, Danica T. Schmidtke, Rachel Werther, Deanna Hausman, Barry L. Stoddard, Brett K. Kaiser, Harmit S. Malik.AcrIIA22 is a novel anti-CRISPR that impairs SpyCas9 activity by relieving DNA torsion of target plasmids. (BioRxiv)
- Zhang Z, Pan S, Liu T, et al. Cas4 nucleases can effect specific integration of CRISPR spacers[J]. Journal of bacteriology, 2019, 201(12): e00747-18. (PMID: 30936372)
- Bhoobalan-Chitty Y, Johansen T B, Di Cianni N, et al. Inhibition of type III CRISPR-Cas immunity by an archaeal virus-encoded anti-CRISPR protein[J]. Cell, 2019, 179(2): 448-458. e11. (PMID: 31564454)
- Cui Y, Wang S, Chen J, et al. Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides[J]. Genome biology, 2020, 21(1): 1-15. (PMID: 32102684)
- Meeske A J, Jia N, Cassel A K, et al. A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity[J]. Science, 2020, 369(6499): 54-59. (PMID: 32467331)
- Jia N, Patel D J. Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins[J]. Nature Reviews Molecular Cell Biology, 2021: 1-17. (PMID: 34089013)
- Lee thesis. Anti-CRISPR Proteins: Applications in Genome Engineering ( https://doi.org/10.13028/xxj4-6a50)
- Song G, Zhang F, Tian C, Gao X, Zhu X, Fan D, Tian Y. Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing. Nucleic Acids Res. 2022 Mar 21;50(5):2836-2853. (PMID: 35188577)